O'Brien; Alison D.

Patent Applications and Registrations

Patent applications and USPTO patent grants for O'Brien; Alison D..The latest application filed is for "methods and compositions based on shiga toxin type 2 protein".

Company Profile

0.7.11

O'Brien; Alison D. - Bethesda MD

*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.

Patent Activity

Patent	Date
Methods and compositions based on Shiga toxin type 2 protein Grant 9,801,931 - O'Brien , et al. October 31, 2	2017-10-31
Methods And Compositions Based On Shiga Toxin Type 2 Protein App 20160243210 - O'BRIEN; Alison D. ; et al.	2016-08-25
Shiga toxoid chimeric proteins Grant 8,846,058 - Smith , et al. September 30, 2	2014-09-30
Humanized Monoclonal Antibodies That Protect Against Shiga Toxin Induced Disease App 20140135481 - Stinson; Jeffrey R. ; et al.	2014-05-15
Methods And Compositions Based On Shiga Toxin Type 1 Protein App 20140023652 - SMITH; Michael ; et al.	2014-01-23
Humanized Monoclonal Antibodies That Protect Against Shiga Toxin Induced Disease App 20100189715 - Stinson; Jeffrey R. ; et al.	2010-07-29
Humanized Monoclonal Antibodies That Protect Against Shiga Toxin Induced Disease App 20100166753 - Stinson; Jeffrey R. ; et al.	2010-07-01
Shiga Toxoid Chimeric Proteins App 20090226469 - Smith; Michael J. ; et al.	2009-09-10
Humanized monoclonal antibodies that protect against shiga toxin induced disease App 20070160607 - Stinson; Jeffrey R. ; et al.	2007-07-12
Humanized monoclonal antibodies that protect against shiga toxin induced disease App 20070003560 - Stinson; Jeffrey R. ; et al.	2007-01-04
Histidine-tagged intimin and methods of using intimin to stimulate an immune response and as an antigen carrier with targeting capability App 20050244425 - McKee, Marian L. ; et al.	2005-11-03
Histidine-tagged intimin and methods of using intimin to stimulate an immune response and as an antigen carrier with targeting capability Grant 6,942,861 - McKee , et al. September 13, 2	2005-09-13
Method of stimulating an immune response by administration of host organisms that express intimin alone or as a fusion protein with one or more other antigens Grant 6,881,411 - Stewart, Jr. , et al. April 19, 2	2005-04-19
Method of stimulating and immune response by administration of host organisms that express intimin alone of as a fusion protein with one of more other antigens App 20030147902 - Stewart, C. Neal JR. ; et al.	2003-08-07
Plants and plant cells expressing histidine tagged intimin Grant 6,406,885 - Stewart, Jr. , et al. June 18, 2	2002-06-18
Histidine-tagged Intimin And Methods Of Using Intimin To Stimulate An Immune Response And As An Antigen Carrier With Targeting Capability App 20020006407 - MCKEE, MARIAN L. ; et al.	2002-01-17
Method of stimulating an immune response by administration of host organisms that express intimin alone or as a fusion protein with one or more other antigens Grant 6,261,561 - Stewart, Jr. , et al. July 17, 2	2001-07-17

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.